Updates
The latest developments from COMED Therapeutics, covering progress across our science, pipeline, team, and broader company activities.
COMED Hooks Increase PI-Positive Cells by 69% in CAPAN-2 Cells
An independent study in CAPAN-2 pancreatic cancer cells found 68.7% more PI-positive objects following treatment with COMED Hooks versus matched nLNP controls.
Beyond Tumor Control: Evidence of Cell-State Reprogramming
An independent proteomic analysis of COMED’s pancreatic cancer program provides evidence of cell-state reprogramming following treatment with COMED Hooks.
The Full Picture: In Vivo Data Confirm COMED Hooks Suppress Tumor Growth
Full in vivo data confirm COMED Hooks suppresses tumor growth in a pancreatic cancer model, with 100% survival and strong tolerability.
Preliminary In Vivo Data Show Slower Tumor Growth with COMED Hooks
Early animal-study results indicate a meaningful difference in tumor growth following treatment with COMED Hooks, alongside ongoing antibody development and preclinical work.